Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of

Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the eight research firms that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month […]

Related Keywords

United States , Stifel Nicolaus , Kevin Bitterman , Raymond James , Venture Fund Xlp Atlas , Citigroup Inc , Disc Medicine Inc , Millennium Management , Nasdaq , Morgan Stanley , Geode Capital Management , Renaissance Technologies , Cantor Fitzgerald , Disc Medicine , Get Free Report , Marketbeat Ratings , Venture Fund , Director Kevin Bitterman , Capital Management , Point Capital Management , Get Free , Disc Medicine Daily , Nasdaq Iron , Iron , Medical , Ratings , Consensus ,